Design, development and production of nano-particle-based anticancer vaccine targeting human aspartyl (asparaginyl) β-hydroxylase (HAAH)

Antzeko izenburuak

• Immunogenicity of a lambda phage-based anti-cancer vaccine targeting HAAH
  nork: Fuller, Steven, et al.
  Argitaratua: (2013)
• Inhibition of tumor growth in vivo by a nanoparticle-based therapeutic cancer vaccine targeting HAAH
  nork: Fuller, Steven, et al.
  Argitaratua: (2013)
• A nanoparticle therapeutic vaccine targeting HAAH stimulates cellular immunity
  nork: Lebowitz, Michael, et al.
  Argitaratua: (2015)
• A cancer therapeutic nanoparticle vaccine targeting HAAH improves 3-week survival from 12.5% to 100% in a mouse model of metastatic breast cancer
  nork: Fuller, Steven, et al.
  Argitaratua: (2014)
• A Radiolabeled Fully Human Antibody to Human Aspartyl (Asparaginyl) β-Hydroxylase Is a Promising Agent for Imaging and Therapy of Metastatic Breast Cancer
  nork: Revskaya, Ekaterina, et al.
  Argitaratua: (2017)